- New study supports testing of Merck’s Ebola vaccine in DRC outbreakNew data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses, could also offer some protection against another.STAT · 1d ago↗ source
- Webinar: From Clinical to Commercial: Talent Strategies for Biopharma GrowthThis webinar provides an assessment of recent job market activity across biopharma and explores how companies approaching commercial readiness or building out sales and marketing teams can navigate…BioSpace · 1d ago↗ source
- Opinion: What Argentina’s World Cup loss should teach American hospitals“Hospitals often make Argentina’s mistake: We confuse continuity with progress,” writes physician, hospital administrator, and bioethicist Basel Tarab.